EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Segmental macular hyperpigmentation: new genes, new clinical implications

Veronica A Kinsler iD, Nicole Knöpfel iD, Satyamaanasa Polubothu iD

British Journal of Dermatology · 2025

DOI: 10.1093/bjd/ljaf254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Veronica A Kinsler und 2 weiteren Autor:innen. Beteiligte Einrichtung: NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology, Great Ormond Street Hospital for Children, London, UK. Hauptthemen laut MEDLINE: Hyperpigmentation, Chromogranins, GTP-Binding Protein alpha Subunits, Gs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health and Social Care Research (NIHR), Great Ormond Street Hospital Children's Charity Livingstone Skin Research Centre, UCL Great Ormond Street Institute of Child Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Segmental macular hyperpigmentation (SMH) is macular hyperpigmentation in a defined developmental pattern, presenting at birth or in the early years. The only known cause of this phenotype has been mosaicism of gene GNAS, as part of McCune–Albright syndrome. It is unknown how often GNAS mosaicism is the cause of SMH presenting to dermatology or whether there are other genetic causes for the phenotype with different clinical implications.

Objectives

To investigate the genetic causes of SMH and the natural history of the condition.

Methods

A prospective cohort of 50 children were recruited consecutively for phenotypic and genotypic studies over a period of 15 years. High-depth next-generation sequencing of affected skin with bioinformatic analysis optimized for mosaic variant detection was performed in 42 children.

Results

Three patients with mosaic GNAS variants were identified, all otherwise well at presentation, but one of whom went on to develop endocrine complications in the follow-up period. Importantly, in a further five patients, new genetic causes were identified. These were pathogenic mosaic variants in single genes (NRAS, n = 2; BRAF, n = 1; PTPN11, n = 1) and a mosaic chromosomal copy number variant (chromosome 5p gain, n = 1), all undetectable in blood. In most cases, the variant allele frequency was extremely low, probably reflecting the very few variant cells in a whole skin biopsy of a macular lesion, and it is possible that causative variants in tested genes are still being missed, even at current sensitivities.

Conclusions

The discovery of these highly disparate genetic causes has important implications for personalized patient management. Specifically, detection of GNAS variants will involve monitoring and investigation of other systems; NRAS/BRAF/PTPN11 will involve discussion of melanoma awareness and the potential of passing on variants as germline diseases to future offspring; and chromosomal abnormalities may have implications in multiple clinical areas. Our findings multiply the known causes of SMH and reveal the importance of genotyping patients presenting to dermatology, even when clinically well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationChromograninsGTP-Binding Protein alpha Subunits, GsHumansMosaicismMaleFemaleChildChild, PreschoolProspective StudiesInfantPhenotypeAdolescentMutationDNA Copy Number Variations

Substanzen

ChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, Gs

Autor:innen und Institutionen

  • NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology, Great Ormond Street Hospital for Children, London, UK.
  • Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute, London, UK.

ORCID-Profile: Veronica A Kinsler, Nicole Knöpfel, Satyamaanasa Polubothu

Förderung

  • National Institute of Health and Social Care Research (NIHR)
  • Great Ormond Street Hospital Children's Charity Livingstone Skin Research Centre
  • UCL Great Ormond Street Institute of Child Health
  • Great Ormond Street Hospital Children’s Charity Livingstone Skin Research Centre

Zitieren

APA

Kinsler, V. A., Knöpfel, N., & Polubothu, S. (2025). Segmental macular hyperpigmentation: new genes, new clinical implications. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf254

Vancouver

Kinsler VA, Knöpfel N, Polubothu S. Segmental macular hyperpigmentation: new genes, new clinical implications. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljaf254

BibTeX
@article{Kinsler2025,
  author = {Kinsler, Veronica A and Knöpfel, Nicole and Polubothu, Satyamaanasa},
  title = {Segmental macular hyperpigmentation: new genes, new clinical implications},
  journal = {British Journal of Dermatology},
  year = {2025},
  doi = {10.1093/bjd/ljaf254}
}
Kostenlos starten →